Ontology highlight
ABSTRACT:
SUBMITTER: Raetz EA
PROVIDER: S-EPMC6142501 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
Raetz Elizabeth A EA Teachey David T DT
Hematology. American Society of Hematology. Education Program 20161201 1
T-cell acute lymphoblastic leukemia (T-ALL) is biologically distinct from its B lymphoblastic (B-ALL) counterpart and shows different kinetic patterns of disease response. Although very similar regimens are used to treat T-ALL and B-ALL, distinctions in response to different elements of therapy have been observed. Similar to B-ALL, the key prognostic determinant in T-ALL is minimal residual disease (MRD) response. Unlike B-ALL, other factors including age, white blood cell count at diagnosis, an ...[more]